The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models-Reference-Cited by-同舟云学术

The B7-H3–Targeting Antibody–Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor Models

Published:2021-02-22 Issue:10 Volume:27 Page:2938-2946
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Kendsersky Nathan M.,Lindsay Jarrett,Kolb E. Anders,Smith Malcolm A.^ORCID,Teicher Beverly A.,Erickson Stephen W.,Earley Eric J.^ORCID,Mosse Yael P.^ORCID,Martinez Daniel,Pogoriler Jennifer^ORCID,Krytska Kateryna,Patel Khushbu^ORCID,Groff David,Tsang Matthew,Ghilu Samson,Wang Yifei,Seaman Steven,Feng Yang,Croix Brad St.,Gorlick Richard^ORCID,Kurmasheva Raushan^ORCID,Houghton Peter J.,Maris John M.^ORCID

Funder

NCI

Giulio D'Angio Endowed Chair

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Deubiquitinating Enzymes in Primary Bone Cancer;Molecular Biotechnology;2024-08-23

2. Lineage-dependence of the neuroblastoma surfaceome defines tumor cell state-dependent and independent immunotherapeutic targets;2024-07-02

3. Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future;Medicinal Research Reviews;2024-06-17

4. CAR T cells redirected to B7-H3 for pediatric solid tumors: Current status and future perspectives;EJC Paediatric Oncology;2024-06

5. Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies;Cancer Research Communications;2024-05-30